LifeMD Long Term Debt 2011-2025 | LFMD
LifeMD Annual Long Term Debt (Millions of US $) |
|
---|---|
2024 | $10 |
2023 | $18 |
2022 | $0 |
2021 | $0 |
2020 | $0 |
2019 | $0 |
2018 | $0 |
2017 | $0 |
2016 | $0 |
2015 | $0 |
2014 | $0 |
2013 | $0 |
2012 | $0 |
2011 | $0 |
2010 | $0 |
LifeMD Quarterly Long Term Debt (Millions of US $) |
|
---|---|
2025-03-31 | $7 |
2024-12-31 | $10 |
2024-09-30 | $13 |
2024-06-30 | $12 |
2024-03-31 | $14 |
2023-12-31 | $18 |
2023-09-30 | $19 |
2023-06-30 | $14 |
2023-03-31 | $13 |
2022-12-31 | |
2022-09-30 | |
2022-06-30 | |
2022-03-31 | |
2021-12-31 | |
2021-09-30 | $11 |
2021-06-30 | $9 |
2021-03-31 | |
2020-12-31 | |
2020-09-30 | |
2020-06-30 | |
2020-03-31 | |
2019-12-31 | |
2019-09-30 | |
2019-06-30 | |
2019-03-31 | |
2018-12-31 | |
2018-09-30 | |
2018-06-30 | |
2018-03-31 | |
2017-12-31 | |
2017-09-30 | |
2017-06-30 | |
2017-03-31 | |
2016-12-31 | |
2016-09-30 | |
2016-06-30 | |
2016-03-31 | |
2015-12-31 | |
2015-09-30 | |
2015-06-30 | |
2015-03-31 | |
2014-12-31 | |
2014-09-30 | |
2014-06-30 | |
2014-03-31 | |
2013-12-31 | |
2013-09-30 | |
2013-06-30 | |
2013-03-31 | |
2012-12-31 | |
2012-09-30 | |
2012-06-30 | |
2012-03-31 | |
2011-12-31 | |
2010-12-31 | $0 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.544B | $0.212B |
LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $143.621B | 26.94 |
CVS Health (CVS) | United States | $84.680B | 10.52 |
Elevance Health (ELV) | United States | $78.955B | 10.19 |
Cencora (COR) | United States | $57.765B | 20.10 |
DiDi Global (DIDIY) | China | $23.297B | 24.75 |
Natera (NTRA) | United States | $21.640B | 0.00 |
Labcorp Holdings (LH) | United States | $21.549B | 17.48 |
BioMerieux (BMXMF) | France | $16.861B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $13.690B | 0.00 |
Solventum (SOLV) | United States | $12.990B | 13.75 |
CochLear (CHEOY) | Australia | $12.847B | 0.00 |
ICON (ICLR) | Ireland | $12.241B | 11.38 |
Revvity (RVTY) | United States | $11.865B | 20.42 |
Viatris (VTRS) | United States | $10.868B | 3.73 |
Avantor (AVTR) | United States | $9.370B | 13.61 |
Medpace Holdings (MEDP) | United States | $9.269B | 24.62 |
HealthEquity (HQY) | United States | $8.917B | 39.06 |
Sonic Healthcare (SKHHY) | Australia | $8.417B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.779B | 15.24 |
Caris Life Sciences,�Inc (CAI) | United States | $6.688B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.952B | 29.17 |
BrightSpring Health Services (BTSG) | United States | $3.769B | 34.58 |
Sotera Health (SHC) | United States | $3.290B | 18.69 |
Surgery Partners (SGRY) | United States | $2.853B | 37.10 |
Alignment Healthcare (ALHC) | United States | $2.712B | 0.00 |
Concentras Parent (CON) | United States | $2.615B | 15.11 |
Organon (OGN) | United States | $2.587B | 2.75 |
GeneDx Holdings (WGS) | United States | $2.432B | 93.65 |
Progyny (PGNY) | United States | $2.080B | 45.79 |
PACS (PACS) | United States | $1.972B | 0.00 |
Ardent Health (ARDT) | United States | $1.970B | 8.40 |
Premier (PINC) | United States | $1.805B | 13.70 |
GoodRx Holdings (GDRX) | United States | $1.729B | 34.57 |
Teladoc Health (TDOC) | United States | $1.493B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.271B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.159B | 8.82 |
CareDx (CDNA) | United States | $1.072B | 16.74 |
Agilon Health (AGL) | United States | $0.989B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
Nutex Health (NUTX) | United States | $0.766B | 11.59 |
QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
Embecta (EMBC) | United States | $0.610B | 4.11 |
InnovAge Holding (INNV) | United States | $0.574B | 0.00 |
SBC Medicals (SBC) | United States | $0.504B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.465B | 10.47 |
Omada Health (OMDA) | $0.450B | 0.00 | |
So-Young (SY) | China | $0.423B | 0.00 |
Enhabit (EHAB) | United States | $0.370B | 30.42 |
Performant Healthcare (PHLT) | United States | $0.333B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.324B | 0.00 |
Beauty Health (SKIN) | United States | $0.265B | 0.00 |
Oncology Institute (TOI) | United States | $0.223B | 0.00 |
DocGo (DCGO) | United States | $0.158B | 25.83 |
Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
KindlyMD (NAKA) | United States | $0.078B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.067B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.062B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
ModivCare (MODV) | United States | $0.055B | 0.00 |
Biodesix (BDSX) | United States | $0.043B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.034B | 0.00 |
OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |